Clinical value of CagA, c‑Met, PI3K and Beclin‑1 expressed in gastric cancer and their association with prognosis

Huang,Xiaojun; Wang,Chaoqun; Sun,Jinmin; Luo,Jun; You,Jiangzhou; Liao,Linchuan; Li,Mingyuan

doi:10.3892/ol.2017.7394

Clinical value of CagA, c‑Met, PI3K and Beclin‑1 expressed in gastric cancer and their association with prognosis

Authors:
- Xiaojun Huang
- Chaoqun Wang
- Jinmin Sun
- Jun Luo
- Jiangzhou You
- Linchuan Liao
- Mingyuan Li
View Affiliations

Affiliations: Department of Microbiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Pathology, Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China
Published online on: November 13, 2017 https://doi.org/10.3892/ol.2017.7394
Pages: 947-955
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer (GC) is the fourth most common type of malignant tumor worldwide, and causes the second highest number of cancer‑associated mortalities in 2012. Gastric tumorigenesis is a multistep and multifactorial process. In the present study, tissue microarray and immunohistochemistry analysis were used to detect cytotoxin‑associated gene A (CagA), c‑Met, phosphatidylinositol‑4,5‑bisphosphate 3‑kinase (PI3K) and Beclin‑1 expression in 121 GC tumors and 120 normal gastric tissues. The clinical relevance and prognostic implications of CagA, c‑Met, PI3K and Beclin‑1 expression in GC patients were analyzed. Furthermore, the Cox proportional hazards model was performed to indicate the independent prognostic factors for GC patients, including various clinicopathological parameters and CagA, c‑Met, PI3K and Beclin‑1 expression. The results indicated that CagA‑positive H. pylori infection, c‑Met, PI3K and Beclin‑1 may have major roles in the oncogenesis, invasion and lymph node metastasis of GC. The disease‑free survival rate was negatively associated with the expression of c‑Met and CagA in tissues, and was positively associated with Beclin‑1 expression. Overall survival was also negatively associated with the expression of c‑Met and PI3K, and was positively associated with Beclin‑1 expression. This indicated that c‑Met and Beclin‑1 may be independent and efficient biomarkers for predicting the DFS of patients with GC. Furthermore, in CagA‑positive H. pylori infection‑associated GC, c‑Met expression was significantly upregulated and Beclin‑1 expression was significantly downregulated. CagA‑positive H. pylori infection therefore associated with the c‑Met signaling pathway and the suppression of autophagy in the neoplasia, invasion and metastasis of GC.

View Figures

View References

1	Stewart BW and Wild CP: World Cancer Report 2014. Geneva: World Health Organization, International Agency for Research on Cancer, WHO Press; 2015
2	Zhang S, Chen P, Huang Z, Hu X, Chen M, Hu S, Hu Y and Cai T: Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a. Sci Rep. 10:97872015. View Article : Google Scholar
3	WHO, . A Survey of Cancer 2014[DB/OL]. http://www.who.int/cancer/country-profiles/en/2014
4	Siegel R, Naishadham D and Jemal A: Cancer statistics for Hispanics/Latinos. CA Cancer J Clin. 62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
5	Li ZX and Kaminishi MA: Comparison of gastric cancer between Japan and China. Gastric Cancer. 12:52–53. 2009. View Article : Google Scholar : PubMed/NCBI
6	International Agency for Research on Cancer, . Helicobatcer pylori Eradication as a Strategy for Preventing Gastric Cancer, IARC Working Group Reports. 8. Lyon: IARC; 2013, http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/Helicobacter_pylori_Eradication.pdfJune 14–2016
7	Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W and Haas R: Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 287:1497–1500. 2000. View Article : Google Scholar : PubMed/NCBI
8	Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M and Hatakeyama M: SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 295:683–686. 2002. View Article : Google Scholar : PubMed/NCBI
9	Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, Murata-Kamiya N, Azuma T and Hatakeyama M: EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J Biol Chem. 280:23130–23137. 2005. View Article : Google Scholar : PubMed/NCBI
10	Peek RM Jr and Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2:28–37. 2002. View Article : Google Scholar : PubMed/NCBI
11	Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN and Nomura A: Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111–2115. 1995.PubMed/NCBI
12	Yang JJ, Yang JH, Kim J, Ma SH, Cho LY, Ko KP, Shin A, Choi BY, Kim HJ, Han DS, et al: Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort. Int J Cancer. 132:2148–2156. 2013. View Article : Google Scholar : PubMed/NCBI
13	Taniguchi K, Yonemura Y, Nojima N, Hirono Y, Fushida S, Fujimura T, Miwa K, Endo Y, Yamamoto H and Watanabe H: The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. Cancer. 82:2112–2122. 1998. View Article : Google Scholar : PubMed/NCBI
14	Toiyama Y, Yasuda H, Saigusa S, Matushita K, Fujikawa H, Tanaka K, Mohri Y, Inoue Y, Goel A and Kusunoki M: Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Int J Cancer. 130:2912–2921. 2012. View Article : Google Scholar : PubMed/NCBI
15	Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He WL, Xu JB and Zan WH: Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma. J Surg Oncol. 106:304–310. 2012. View Article : Google Scholar : PubMed/NCBI
16	Yıldız Y, Sokmensuer C and Yalcin S: Evaluation of c-Met, HGF, and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors. Onco Targets Ther. 9:5809–5817. 2016. View Article : Google Scholar : PubMed/NCBI
17	Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W and Naumann M: Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol. 161:249–255. 2003. View Article : Google Scholar : PubMed/NCBI
18	Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, White M, Reichelt J and Levine B: Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 338:956–959. 2012. View Article : Google Scholar : PubMed/NCBI
19	Vasconcelos AC, Wagner VP, Meurer L, Vargas PA, de Souza LB, Fonseca FP, Squarize CH, Castilho RM and Martins MD: Immunoprofile of c-MET/PI3K signaling in human salivary gland tumors. Oral Surg Oral Med Oral Pathol Oral Radiol. 120:238–247. 2015. View Article : Google Scholar : PubMed/NCBI
20	Zhuo B, Li Y, Li Z, Qin H, Sun Q, Zhang F, Shen Y, Shi Y and Wang R: PI3K/Akt signaling mediated Hexokinase-2 expression inhibits cell apoptosis and promotes tumor growth in pediatric osteosarcoma. Biochem Biophys Res Commun. 464:401–406. 2015. View Article : Google Scholar : PubMed/NCBI
21	Jung KA, Choi BH and Kwak MK: The c-MET/PI3K signaling is associated with cancer resistance to doxorubicin and photodynamic therapy by elevating BCRP/ABCG2 expression. Mol Pharmacol. 87:465–476. 2015. View Article : Google Scholar : PubMed/NCBI
22	Wu J, Chen C and Zhao KN: Phosphatidylinositol 3-kinase signaling as a therapeutic target for cervical cancer. Curr Cancer Drug Targets. 13:143–156. 2013. View Article : Google Scholar : PubMed/NCBI
23	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th. Springer; New York: pp. 191–200. 2010
24	Okada F: Inflammation-related carcinogenesis: Current findings in epidemiological trends, causes and mechanisms. Yonago Acta Med. 57:65–72. 2014.PubMed/NCBI
25	Wajih N, Walter J and Sane DC: Vascular origin of a soluble truncated form of the hepatocyte growth factor receptor (c-met). Circ Res. 90:46–52. 2002. View Article : Google Scholar : PubMed/NCBI
26	Porter J: Small molecule c-Met kinase inhibitors: A review of recent patents. Expert Opin Ther Pat. 20:159–177. 2010. View Article : Google Scholar : PubMed/NCBI
27	Oliveira MJ, Costa AC, Costa AM, Henriques L, Suriano G, Atherton JC, Machado JC, Carneiro F, Seruca R, Mareel M, et al: Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner. J Biol Chem. 281:34888–34896. 2006. View Article : Google Scholar : PubMed/NCBI
28	Snider JL and Cardelli JA: Helicobacter pylori induces cancer cell motility independent of the c-Met receptor. J Carcinog. 8:72009. View Article : Google Scholar : PubMed/NCBI
29	Hu Y, Li L, Yin W, Shen L, You B and Gao H: Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel. Mol Med Rep. 10:2051–2058. 2014. View Article : Google Scholar : PubMed/NCBI